Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,031,444,744.08
- Feb. 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 3, 2017 | CMO | 5,390 | $144.71 | Sell | $779,986.90 | |
| Nov. 3, 2017 | EVP | 2,330 | $149.50 | Sell | $348,335.00 | |
| Nov. 3, 2017 | Director | 7,073 | $143.05 | Sell | $1,011,792.65 | |
| Oct. 31, 2017 | EVP | 40,000 | $145.05 | Sell | $5,802,000.00 | |
| Oct. 31, 2017 | COO | 75,000 | $145.06 | Sell | $10,879,500.00 | |
| Oct. 31, 2017 | CMO | 60,000 | $145.05 | Sell | $8,703,000.00 | |
| Oct. 27, 2017 | EVP | 6,290 | $143.97 | Sell | $905,571.30 | |
| Oct. 16, 2017 | COO | 2,125 | $155.61 | Sell | $330,671.25 | |
| Oct. 16, 2017 | CMO | 1,718 | $155.19 | Sell | $266,616.42 | |
| Oct. 12, 2017 | EVP | 2,125 | $152.93 | Sell | $324,976.25 | |
| Oct. 2, 2017 | CMO | 3,437 | $151.64 | Sell | $521,186.68 | |
| Aug. 31, 2017 | EVP | 1,796 | $160.00 | Sell | $287,360.00 | |
| Aug. 7, 2017 | CFO | 4,250 | $155.39 | Sell | $660,407.50 | |
| Aug. 7, 2017 | SVP | 1,289 | $152.88 | Sell | $197,062.32 | |
| Aug. 3, 2017 | CMO | 5,390 | $154.17 | Sell | $830,976.30 | |
| Aug. 3, 2017 | EVP | 2,330 | $155.72 | Sell | $362,827.60 | |
| Aug. 2, 2017 | CFO | 2,155 | $154.17 | Sell | $332,236.35 | |
| Aug. 2, 2017 | CMO | 1,796 | $154.13 | Sell | $276,817.48 | |
| Aug. 2, 2017 | SVP | 1,289 | $151.80 | Sell | $195,670.20 | |
| July 31, 2017 | SVP | 860 | $152.99 | Sell | $131,571.40 | |
| July 31, 2017 | CEO | 11,063 | $152.81 | Sell | $1,690,537.03 | |
| July 31, 2017 | EVP | 2,125 | $152.99 | Sell | $325,103.75 | |
| July 21, 2017 | EVP | 28,625 | $160.93 | Sell | $4,606,621.25 | |
| July 21, 2017 | SVP | 43,443 | $161.07 | Sell | $6,997,364.01 | |
| July 21, 2017 | CEO | 216,624 | $160.96 | Sell | $34,867,799.04 | |
| July 21, 2017 | CMO | 46,733 | $160.96 | Sell | $7,522,143.68 | |
| July 21, 2017 | CFO | 133,750 | $160.98 | Sell | $21,531,075.00 | |
| July 19, 2017 | EVP | 10,829 | $161.00 | Sell | $1,743,469.00 | |
| July 17, 2017 | CMO | 573 | $129.85 | Sell | $74,404.05 | |
| July 3, 2017 | CMO | 3,438 | $127.80 | Sell | $439,376.40 | |
| June 21, 2017 | CMO | 5,157 | $132.87 | Sell | $685,210.59 | |
| June 21, 2017 | SVP | 2,577 | $133.36 | Sell | $343,668.72 | |
| June 5, 2017 | EVP | 7,500 | $130.00 | Sell | $975,000.00 | |
| June 2, 2017 | CEO | 147,101 | $129.50 | Sell | $19,049,579.50 | |
| June 2, 2017 | Director | 1,176 | $128.44 | Sell | $151,045.44 | |
| June 2, 2017 | EVP | 70,969 | $128.06 | Sell | $9,088,290.14 | |
| May 2, 2017 | CMO | 8,979 | $121.05 | Sell | $1,086,907.95 | |
| April 28, 2017 | CEO | 157,200 | $119.50 | Sell | $18,785,400.00 | |
| April 5, 2017 | CMO | 8,021 | $114.00 | Sell | $914,394.00 | |
| April 3, 2017 | CMO | 2,291 | $108.85 | Sell | $249,375.35 | |
| March 29, 2017 | SVP | 1,688 | $106.30 | Sell | $179,434.40 | |
| March 29, 2017 | CMO | 13,750 | $106.65 | Sell | $1,466,437.50 | |
| March 29, 2017 | EVP | 80,500 | $107.63 | Sell | $8,664,215.00 | |
| Jan. 11, 2017 | Director | 8,000 | $82.48 | Sell | $659,840.00 | |
| Jan. 4, 2017 | Director | 6,500 | $77.13 | Sell | $501,345.00 | |
| Dec. 29, 2016 | Director | 6,500 | $74.33 | Sell | $483,145.00 | |
| Dec. 21, 2016 | Director | 6,500 | $74.16 | Sell | $482,040.00 | |
| Dec. 14, 2016 | Director | 6,500 | $77.52 | Sell | $503,880.00 | |
| Nov. 30, 2016 | Director | 6,500 | $83.48 | Sell | $542,620.00 | |
| Nov. 23, 2016 | Director | 6,500 | $86.47 | Sell | $562,055.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Bruce Sachs, Kristen Ambrose, Elaine Ullian, Stuart A. Arbuckle, Joy Liu, Jeffrey Leiden, Wayne Joseph Riley, Kenneth L Horton, Megan E Pace, Megan Pace, Edward Morrow Atkinson III, Jonathan Biller, Christiana Stamoulis, Paul Silva, Thomas Graney, Jeffrey M. Leiden, Sangeeta N. Bhatia, Mark E Bunnage, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Ian F. Smith, Kenneth Horton, William D Young, and Paul M. Silva
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on Feb. 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.